Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Biomarin Pharmaceutical Q4 Sales $537.54M Beat $536.97M Estimate

Biomarin Pharmaceutical (NASDAQ:BMRN) reported quarterly sales of $537.54 million which beat the analyst consensus estimate of $536.97 million by 0.11 percent. This is a 19.50 percent increase over sales of $449.81

byBenzinga Newsdesk

February 27, 2023

1 minute read

Biomarin Pharmaceutical (NASDAQ:BMRN) reported quarterly sales of $537.54 million which beat the analyst consensus estimate of $536.97 million by 0.11 percent. This is a 19.50 percent increase over sales of $449.81 million the same period last year.